Sarepta Therapeutics (SRPT) Surged To Over A 10-Month High On Study Results

Sarepta Therapeutics (SRPT) announced positive muscle biopsy results from its Phase 1/2 study of golodirsen Wednesday morning. The study achieved statistical significance on all primary and secondary biological endpoints.

from RTT - Before the Bell http://ift.tt/2wb7Iv8
via IFTTT